The ZIOP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ZIOP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ZIOP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ZIOP Detailed Price Forecast - CNN Money||View ZIOP Detailed Summary - Google Finance|
|View ZIOP Detailed Summary - Yahoo! Finance||View ZIOP Stock Research & Analysis - Zacks.com|
|View ZIOP Trends & Analysis - Trade-Ideas||View ZIOP Major Holders - Barrons|
|View ZIOP Call Transcripts - NASDAQ||View ZIOP Breaking News & Analysis - Seeking Alpha|
|View ZIOP Annual Report - CompanySpotlight.com||View ZIOP OTC Short Report - OTCShortReport.com|
|View ZIOP Fundamentals - TradeKing||View ZIOP SEC Filings - Bar Chart|
|View Historical Prices for ZIOP - The WSJ||View Performance/Total Return for ZIOP - Morningstar|
|View the Analyst Estimates for ZIOP - MarketWatch||View the Earnings History for ZIOP - CNBC|
|View the ZIOP Earnings - StockMarketWatch||View ZIOP Buy or Sell Recommendations - MacroAxis|
|View the ZIOP Bullish Patterns - American Bulls||View ZIOP Short Pain Metrics - ShortPainBot.com|
|View ZIOP Stock Mentions - StockTwits||View ZIOP Stock Mentions - PennyStockTweets|
|View ZIOP Stock Mentions - Twitter||View ZIOP Investment Forum News - Investor Hub|
|View ZIOP Stock Mentions - Yahoo! Message Board||View ZIOP Stock Mentions - Seeking Alpha|
|View Insider Transactions for ZIOP - SECform4.com||View Insider Transactions for ZIOP - Insider Cow|
|View ZIOP Major Holdings Summary - CNBC||View Insider Disclosure for ZIOP - OTC Markets|
|View Insider Transactions for ZIOP - Yahoo! Finance||View Institutional Holdings for ZIOP - NASDAQ|
|View ZIOP Stock Insight & Charts - FinViz.com||View ZIOP Investment Charts - StockCharts.com|
|View ZIOP Stock Overview & Charts - BarChart||View ZIOP User Generated Charts - Trading View|
Biotech Stocks on the Move
Posted on Monday January 21, 2019
HENDERSON, NV / ACCESSWIRE / January 21, 2019 / Biotech has been one of the hottest sectors this month. Investors are intrigued by the increase in M&A. Now's a great time to start researching some oversold ...
Ziopharm Oncology Posts Letter to Stockholders
Posted on Monday January 07, 2019
The new license agreement helped pave the way for us to raise $50 million in a private placement from existing investors, secure a clinical collaboration with Regeneron Pharmaceuticals for Controlled IL-12 and announce a joint venture with committed funding of up to $35 million to bring our Sleeping Beauty platform for CD19-specific CAR-T to China. As we begin 2019, Ziopharm is already better.
Ziopharm Oncology (ZIOP) in Focus: Stock Moves 6.2% Higher
Posted on Friday December 28, 2018
Ziopharm Oncology (ZIOP) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets
Posted on Thursday December 27, 2018
Ziopharm Oncology, Inc. (ZIOP) today responded to the recent decline in the Company’s stock price, which accelerated greatly on December 26, 2018, the same day that the broader market and all indexes were up significantly. To the extent this price drop may have been attributable to any market confusion over exclusivity to its assets, the Company wishes to make clear the terms of its exclusivity to such assets. “Our stock price is significantly down of late, and we want to assure the market that our business fundamentals are unchanged and we are optimistic about Ziopharm’s future especially in light of the recent announcements we made with regards to our restructured relationship with Intrexon, the securing of a clean and longer-term balance sheet, and two partnerships with Regeneron and Eden BioCell.